Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for Tinnitus
NCT07190482Phase 1Completed
- Sponsor
- Universidade de São Paulo
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in tinnitus comparing OLANZAPINE ARM with PLACEBO ARM (2 arms). Primary endpoint: Reduction in Tinnitus Symptoms at 12 weeks. Started Oct 2023; status: completed.
02
Drugs
olanzapine
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT07190482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07190482.